Last quarter (Q4 2022), Pharmaxis Ltd's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Pharmaxis Ltd's net income was AU$―. See Pharmaxis Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	-	AU$ 7.43M	AU$ 6.68M	AU$ 7.03M	AU$ 5.68M	AU$ 7.28M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	AU$ 7.43M	AU$ 6.68M	AU$ 7.03M	AU$ 5.68M	AU$ 7.28M
Operating Expense	-	AU$ 30.19M	AU$ 27.32M	AU$ 28.49M	AU$ 31.56M	AU$ 33.63M
Operating Income	-	AU$ -22.77M	AU$ -20.64M	AU$ -21.47M	AU$ -25.88M	AU$ -26.35M
Net Non Operating Interest Income Expense	-	AU$ 13.61M	AU$ -319.00K	AU$ 2.52M	AU$ 671.00K	AU$ 35.00K
Other Income Expense	-	AU$ 7.22M	AU$ 17.99M	AU$ 5.00M	AU$ 5.16M	AU$ 32.57M
Pretax Income	-	AU$ -1.94M	AU$ -2.97M	AU$ -13.94M	AU$ -20.06M	AU$ 6.42M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ -8.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -1.94M	AU$ -2.97M	AU$ -13.94M	AU$ -20.06M	AU$ 6.43M
Basic EPS	-	AU$ >-0.01	AU$ >-0.01	AU$ -0.04	AU$ -0.05	-
Diluted EPS	-	AU$ >-0.01	AU$ >-0.01	AU$ -0.04	AU$ -0.05	-
Basic Average Shares	-	AU$ 562.90M	AU$ 407.28M	AU$ 394.74M	AU$ 381.39M	-
Diluted Average Shares	-	AU$ 562.90M	AU$ 407.28M	AU$ 394.74M	AU$ 381.39M	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -1.94M	AU$ -2.97M	AU$ -13.94M	AU$ -20.06M	AU$ 6.43M
Normalized Income	-	AU$ -1.94M	AU$ -2.97M	AU$ -13.94M	AU$ -20.06M	AU$ 6.43M
Interest Expense	-	AU$ -13.46M	AU$ 369.00K	-	AU$ 238.00K	AU$ 563.00K
EBIT	-	AU$ -15.39M	AU$ -2.60M	AU$ -21.47M	AU$ -19.82M	AU$ 6.98M
EBITDA	-	AU$ -12.15M	AU$ 551.00K	AU$ -18.23M	AU$ -17.20M	AU$ 10.33M

Currency in AUD

Pharmaxis Ltd Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing